Twenty-three years after the original Shadow Hearts clawed its way onto the PlayStation 2, the series’ creator is still trying to get its unofficial follow-up off the ground. Fresh reporting out of Japan today confirms that PENNY BLOOD, the dark RPG positioned as a spiritual successor to Shadow Hearts, remains without a publisher, and that the core game’s production has stalled. The team behind it, Studio Wild Rose, has not walked away from the project, though, and is now using an unusual bridge to keep the IP alive: a novel.

The update, reported by the Japanese outlet AUTOMATON, is a reminder of how brutal the gap between crowdfunding success and commercial release can be for mid-budget RPGs. It also raises a question that keeps surfacing across the Japanese games industry in 2026: when a beloved creator has the name recognition but not the capital, what happens to the game in between?

What Happened: The PENNY BLOOD Update, In Plain Terms

Matsuzo Machida, the creator and director tied to both the original Shadow Hearts series and its would-be successor PENNY BLOOD, has given a fresh status check on the project, and the headline is not good news for anyone who backed it years ago hoping to play it soon. According to AUTOMATON’s report, Studio Wild Rose still has not locked in a publisher for PENNY BLOOD, and development on the main game has not moved forward in any meaningful way since funding dried up. Coverage of the Japanese RPG market from outlets like Famitsu has tracked similar funding gaps for mid-tier studios throughout 2026.

That is the blunt part of the update. The more interesting part is what the studio is doing about it. Rather than shelving the property entirely, Studio Wild Rose is producing a novel set in the PENNY BLOOD universe, a project reported under the Japanese title 「ペニーブラッド・リバイオレンス」 (commonly rendered in English-language coverage as Penny Blood: Re:Vengeance, though that English rendering is not itself confirmed in the original reporting). The goal, per the report, is straightforward: keep the brand visible, build awareness, and make the IP look attractive enough that a publisher finally signs on.

It is a workaround, not a fix. A tie-in novel does not ship a video game, and nothing in the current reporting puts a release date, a budget figure, a platform list, or a price tag on PENNY BLOOD itself. What the update does confirm is that the project is alive, that the people behind it have not given up, and that they are improvising a path forward that most RPG studios never have to attempt.

Who Is Behind PENNY BLOOD

Matsuzo Machida built his reputation on Shadow Hearts, a PS2-era JRPG series known for its horror-tinged setting, its oddball judgment ring battle system, and a sense of humor that stood out even in a genre full of eccentric design choices. When the Shadow Hearts trademark stayed locked up with its original publisher, Machida and his collaborators did what a growing number of displaced Japanese RPG veterans have done this decade: they built a new studio, Studio Wild Rose, and designed a spiritual successor instead of fighting over the old name.

That successor is PENNY BLOOD. The pitch was simple for fans who grew up on the original trilogy: the same creative voice, a similar tone, and a battle system built in the same spirit, just under a new banner. It is the same playbook that has worked for other displaced RPG and action creators chasing a familiar feeling without the rights to the familiar name, and shattered.io has covered a similar dynamic recently in its report on Grasshopper Manufacture’s exit from NetEase, where a storied Japanese studio also had to re-chart its own course after a corporate relationship ended.

The Kickstarter Origin Story

PENNY BLOOD did not start as a pitch to a big publisher. It started on Kickstarter, where Studio Wild Rose ran a double campaign in 2022 that, according to reporting at the time, raised roughly ¥379 million from backers eager to fund a true follow-up to Shadow Hearts. For a Japanese RPG crowdfunding effort, that is a serious number, and it generated real momentum and real press coverage in a genre that rarely sees crowdfunding campaigns of that size succeed.

Momentum is not the same as runway, though. Reports indicate the Kickstarter funds had run out by autumn 2023, well before the game reached a shippable state. That is the structural problem crowdfunded RPGs keep running into: ¥379 million sounds like a lot of money until it is split across years of development, a growing team, engine licensing, voice work, and localization. For context on how fast modern RPG budgets scale even for studios with far more backing, see shattered.io’s coverage of Blood of Dawnwalker’s $40 million budget and the AAA pricing debate it reopened.

Why the Publisher Search Keeps Stalling

Here is the part that should worry fans more than the lack of a release date: a project that already secured funding from thousands of individual backers in 2022 still cannot close a publishing deal in late 2026. That is not a quick gap, it is a multi-year one, and it points to something beyond simple bad timing.

As GamesIndustry.biz has documented repeatedly this year, publishers evaluating a project like PENNY BLOOD are not just looking at the pitch deck Machida and his team put together. They are looking at where the money ran out, how far the build actually got, what it would cost to finish, and whether a mid-budget horror RPG with a cult following can move enough units to justify the investment. None of that is confirmed publicly in the current reporting, but the pattern, funding exhausted mid-development, no publisher willing to step in to finish the job, is one that has played out before in the Japanese indie and mid-tier RPG space.

It also sits inside a broader industry mood. 2026 has been a year of consolidation and caution at the publisher level, not experimentation. shattered.io’s reporting on Square Enix splitting FF7 Revelation across two development teams shows that even the biggest, best-funded Japanese RPG projects are being managed more conservatively than they were a few years ago. In that climate, an unfinished, unproven spiritual successor from a comparatively small studio is a harder sell than it would have been during the crowdfunding boom years.

The Novel Strategy: Penny Blood Re:Vengeance

Rather than sit on a stalled project, Studio Wild Rose is trying to generate new attention for PENNY BLOOD through a different medium entirely. The studio is producing a novel in the PENNY BLOOD universe, reported in Japanese as 「ペニーブラッド・リバイオレンス」. English-language coverage has been rendering that as Penny Blood: Re:Vengeance, though that specific English title has not been independently confirmed beyond the Japanese-language original.

According to the reporting, the purpose of the novel is explicit: raise the profile of the PENNY BLOOD intellectual property and make it more attractive to a publisher who might otherwise pass on an unfinished game with a complicated funding history. It is a cheaper, faster way to put new PENNY BLOOD material in front of an audience than continuing to pour resources into a stalled game build, and it keeps the brand from disappearing from conversation entirely while the studio looks for a partner.

Whether it works is an open question. Tie-in novels have built audiences for dormant game franchises before, but they have rarely been the deciding factor in landing a publisher deal on their own. It is a signal of intent more than a guaranteed fix, and it tells backers that Studio Wild Rose is still actively working the problem rather than letting PENNY BLOOD quietly die.

Historical Context: Shadow Hearts and the Spiritual Successor Trend

The original Shadow Hearts trilogy shipped on PlayStation 2 in the early 2000s and built a lasting cult following, documented in detail on its Wikipedia entry, for its judgment ring combat mechanic and its willingness to mix horror atmosphere with broad comedy. That combination made it stand out in a JRPG market dominated by Final Fantasy and Dragon Quest, and it is exactly the kind of back-catalog strength that makes a “spiritual successor” pitch viable years later: there is a built-in audience that remembers the original fondly and wants more of that specific tone.

PENNY BLOOD is far from the only project chasing that formula in 2026. The games industry has leaned hard into “spiritual successor” and long-delayed revival pitches this year, from reboots of dormant franchises to studios built entirely around recreating a specific creative team’s old magic. shattered.io covered a similar dynamic with L.A. Noire 2 buzz returning fifteen years after the original, where renewed fan interest in a long-dormant property outpaced any actual confirmation from the rights holder. The common thread across these stories is simple: nostalgia generates attention fast, but attention does not automatically generate funding, a publisher, or a finished game.

Market Impact: What This Means for Mid-Budget JRPGs

PENNY BLOOD‘s stall is a useful case study for the wider mid-budget RPG market, which has had a rough few years squeezed between ballooning AAA budgets and a flood of cheap, fast-to-produce indie titles. Crowdfunding was supposed to be the bridge that let experienced creators like Machida skip the traditional publisher gatekeeping entirely. What PENNY BLOOD shows is that crowdfunding can cover a launch phase, but it rarely covers a full development cycle for a genre as content-heavy as a story-driven RPG.

That has knock-on effects for how publishers view pitches from similar studios going forward. A publisher weighing whether to pick up a crowdfunded, partially built RPG now has a visible, ongoing example of how that bet can go: years of delay, a funding shortfall, and a studio forced into side projects just to stay relevant. It is not a dealbreaker for the genre, but it is one more data point pushing publishers toward safer, more established franchises, the kind of calculated bet seen in Fire Emblem: Fortune’s Weave topping Japan’s charts at 127,000 units, rather than untested spiritual successors, even ones backed by a recognizable creator name.

Competitive Landscape: How PENNY BLOOD Compares to Other Stalled Revivals

PENNY BLOOD is not operating in isolation. A handful of other high-profile, creator-driven revival projects have hit similar walls in 2026, each for slightly different reasons, including the skepticism surrounding Starfield 2’s existence after doubts from a former Bethesda developer. The table below lays out how PENNY BLOOD’s situation compares with other recent cases of stalled or uncertain long-awaited sequels and spiritual successors covered in recent gaming coverage.

Project Status as of October 2026 Core Obstacle Funding Source
PENNY BLOOD (Studio Wild Rose) No publisher; main development stalled; novel in production Kickstarter funds exhausted before completion 2022 Kickstarter campaign (~¥379 million)
L.A. Noire 2 Fan-driven speculation; no official confirmation from Rockstar No confirmed development or publisher commitment None confirmed; studio silent
Starfield 2 Existence doubted by a former Bethesda developer No confirmed greenlight from Bethesda N/A (internal studio funding, unconfirmed)
FF7 Revelation (Square Enix) In active development, but split across two teams Internal resourcing and scope management Square Enix internal funding

What sets PENNY BLOOD apart is that it is the only project on that list with a confirmed, named funding event, a specific campaign, a specific year, and a reported total. That transparency is both a strength and a liability: backers know exactly how much money came in and roughly when it ran out, which makes the current stall harder to spin as anything other than a funding shortfall.

Timeline: PENNY BLOOD From Crowdfunding to Today

Tracking the public record on PENNY BLOOD shows a project that peaked early and has been searching for its next step ever since. The table below lines up the confirmed milestones reported so far.

Period Milestone Reported Detail
2022 Kickstarter campaign launches Double campaign raises approximately ¥379 million
Autumn 2023 Crowdfunding budget exhausted Development funds reported as depleted before game completion
2023-2026 Publisher search continues No publisher secured; main game development reportedly stalled
October 2026 Machida gives status update Confirms no publisher yet; reveals tie-in novel in production, per AUTOMATON

What’s Still Unconfirmed

It is worth being precise about what this update does not tell us, because speculation has filled in gaps on crowdfunded projects like this one before. As of this report, there is no confirmed release date for PENNY BLOOD, no confirmed platform list, no confirmed price, no confirmed current team size, and no publicly verified, complete on-record quote from Machida in English-language reporting. The English title Penny Blood: Re:Vengeance is the common rendering used in coverage, but the original source confirms only the Japanese title. Readers should treat any more specific claims circulating online, a 2027 launch window, a PlayStation exclusivity deal, a specific publisher name, as unverified until a named outlet or Studio Wild Rose confirms them directly.

Analysis: Why Machida Is Choosing Transparency Over Silence

There is a version of this story where Studio Wild Rose simply goes quiet and lets PENNY BLOOD fade from the conversation, the way plenty of crowdfunded projects do when the money runs out and there is nothing new to announce. Machida and his team chose the opposite path: give a direct, honest update, admit the publisher search has not succeeded, and show backers a concrete, tangible side project instead of vague reassurances.

As VG247 and other outlets covering crowdfunded games have noted, that is a defensible strategy for a studio whose main asset is trust built with the same backers who already funded one campaign. Crowdfunded game studios live and die by their relationship with that original backer base, since those are the people most likely to fund a second round, pre-order day one, or spread word of mouth when a publisher deal finally lands. Going dark erodes that trust fast. A clear, if disappointing, update at least keeps the line of communication open, and a novel gives backers something to actually hold in exchange for their patience.

Predictions: Where PENNY BLOOD Goes From Here

Based on the pattern of this update and the broader state of the mid-budget JRPG market, here is how this is likely to play out over the next year or two.

  • The novel ships before the game sees any major update. Studio Wild Rose has a far shorter path to finishing a tie-in novel than to finishing a stalled RPG, so expect Penny Blood: Re:Vengeance (or whatever its final English title becomes) to reach an audience well before any new gameplay reveal.
  • A publisher deal, if it comes, will likely be announced alongside new funding, not before it. Publishers taking on a project with this funding history will want to control the narrative around a relaunch, bundling a publishing deal with a fresh investment announcement rather than a quiet signing.
  • Expect more Japanese mid-tier studios to test the “transition media” playbook. If the novel strategy generates even modest buzz for PENNY BLOOD, other funding-strapped studios with dormant RPG IP are likely to copy it rather than invent a new approach.
  • Full release, if it happens, is years away rather than months. Nothing in the current reporting suggests development has meaningfully restarted, so even an optimistic scenario puts a shippable build well beyond 2026.
  • Fan patience will keep thinning the longer this drags on. Crowdfunding backers from 2022 are now four years removed from their pledge with no playable build to show for it, and that is the kind of gap that tends to sour even loyal fanbases if it stretches much further.

What Backers and Fans Should Watch Next

For anyone who backed the original 2022 campaign or has simply been following PENNY BLOOD since it was announced, the practical next steps to watch are narrow but concrete: a confirmed English title and release window for the novel, any update to Studio Wild Rose’s own channels about the main game’s development status, and, most importantly, any named publisher entering talks. None of those have happened yet as of this report. Until one does, treat PENNY BLOOD as a project that is alive but not moving, which is a very different thing from a project that has been cancelled outright.

Frequently Asked Questions

What is PENNY BLOOD?
PENNY BLOOD is a dark RPG in development at Studio Wild Rose, positioned as a spiritual successor to the Shadow Hearts series. It is led by Matsuzo Machida, the creator and director associated with the original Shadow Hearts games.

Does PENNY BLOOD have a publisher yet?
No. As of the latest update reported by AUTOMATON, PENNY BLOOD still does not have a secured publisher, years after its original 2022 Kickstarter campaign.

Has PENNY BLOOD been cancelled?
No confirmation of cancellation exists. Studio Wild Rose has stated it has not given up on the project, even though main game production has reportedly not progressed.

How much money did PENNY BLOOD raise on Kickstarter?
Reports place the total from the 2022 double Kickstarter campaign at approximately ¥379 million. Those funds were reportedly exhausted by autumn 2023.

What is Penny Blood: Re:Vengeance?
It is a novel set in the PENNY BLOOD universe, reported in Japanese as 「ペニーブラッド・リバイオレンス」. Studio Wild Rose is producing it to raise the IP’s profile and attract a publisher. The English title used in coverage is not independently confirmed.

Is PENNY BLOOD connected to the original Shadow Hearts games?
Not officially. PENNY BLOOD is described as a spiritual successor rather than a direct sequel, since the Shadow Hearts trademark is not held by Studio Wild Rose or Machida.

When will PENNY BLOOD be released?
No release date has been confirmed. Current reporting does not establish a release window, platform list, or price for the game.

Who is Matsuzo Machida?
Matsuzo Machida is the creator and director associated with the Shadow Hearts series and is leading the PENNY BLOOD project at Studio Wild Rose.